共 396 条
[21]
Fissler-Eckhoff A(2006)Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2483-1124
[22]
Lorenz-Salehi F(2011)Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis Radiat Oncol 6 48-2294
[23]
Scheil-Bertram S(2018)Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation JAMA Oncol 4 1123-338
[24]
Traut A(2016)Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy Ann Oncol 27 2288-30
[25]
du Bois A(2017)Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases J Neuro-Oncol 133 331-558
[26]
Hicks DG(2017)Phase 1 study of Ipilimumab combined with whole brain radiation therapy or radiosurgery for melanoma patients with brain metastases Int J Radiat Oncol Biol Phys 99 22-394
[27]
Short SM(2018)Safety of combined PD-1 pathway inhibition and intracranial radiation therapy in non-small cell lung Cancer J Thorac Oncol 13 550-126
[28]
Prescott NL(2016)BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis Melanoma Res 26 387-4136
[29]
Tarr SM(2015)LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases J Neuro-Oncol 122 121-1609
[30]
Coleman KA(2005)Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy J Clin Oncol 23 4127-93